ER-65250

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameER-65250
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionRetinoic acid receptor alpha agonists
TargetsRetinoic acid receptor alpha
Therapy Area/IndicationsImmune System DiseasesSkin DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEisai Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEisai Co Ltd
Active IndicationsN/A
Inactive IndicationsImmune System DiseasesSkin DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A